Lasa Supergenerics Limited
NSE: LASA.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Omkar Pravin Herlekar
- Employees
- 77
- Headquarters
- Mumbai, India
- IPO year
- 2017
- Market cap
- ₹411.3M
- Website
- https://lasalabs.com
Loading LASA…
Loading profile data…Frequently asked questions about LASA
What does Lasa Supergenerics Limited (LASA.NS) do?
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporate...
Where does LASA.NS trade?
Lasa Supergenerics Limited (LASA.NS) trades on the National Stock Exchange of India.
What sector is LASA.NS in?
Lasa Supergenerics Limited (LASA.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lasa Supergenerics Limited?
Omkar Pravin Herlekar is the chief executive officer of Lasa Supergenerics Limited (LASA.NS).
Where is Lasa Supergenerics Limited headquartered?
Lasa Supergenerics Limited is headquartered in India.
Does LASA.NS pay a dividend?
Lasa Supergenerics Limited (LASA.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LASA.NS go public?
Lasa Supergenerics Limited (LASA.NS) completed its initial public offering in 2017.